论文部分内容阅读
流行性出血热(EHF)在我国流行广泛,病情重.为寻求有效的治疗药物,我们对187例 EHF患者进行了病毒唑随机双盲治疗研究,同时动态测定纤溶酶原(PLG)、抗凝血酶-Ⅲ(AT-Ⅲ)、纤维蛋白原(FIG)、血小板计数(PLAT)及纤维蛋白(原)降解物(FDP),以观察该药对EHF 患者凝血机制的影响.
Epidemic haemorrhagic fever (EHF) is widely prevalent in our country and has a serious illness.For the purpose of seeking effective therapeutic drugs, we conducted a randomized, double-blind treatment study of 187 patients with EHF and measured the activity of plasminogen (PLG) (AT-Ⅲ), fibrinogen (FIG), platelet count (PLAT) and fibrin (FDP) in order to observe the effect of this drug on the coagulation mechanism of EHF patients.